Literature DB >> 7962678

Tricyclic antidepressant concentrations in plasma: an estimate of their sensitivity and specificity as a predictor of response.

P J Perry1, C Zeilmann, S Arndt.   

Abstract

An analysis of the literature on tricyclic antidepressant level in blood using receiver operating characteristics curves as the primary statistical tool was performed. For nortriptyline, a significant curvilinear relationship between therapeutic response and nortriptyline was observed that ranged from 58 to 148 ng/ml. The sensitivity and specificity for the nortriptyline therapeutic window were 78 and 61%, respectively. The response rate within the therapeutic range was 66% versus 26% outside the therapeutic range. For desipramine, a significant linear relationship between therapeutic response and desipramine concentration in plasma was observed. The threshold concentration in plasma for therapeutic response was 116 ng/ml. The sensitivity and specificity for the desipramine threshold level in blood were 81 and 59%, respectively. The response rate above the threshold level was 51% versus 15% below the therapeutic threshold concentration. For imipramine, a significant curvilinear relationship between therapeutic response and total imipramine (imipramine+desipramine) concentration in plasma was observed between 175 and 350 ng/ml. The sensitivity and specificity for the total imipramine concentrations in plasma were 52 and 74%, respectively. The response rate within the therapeutic range was 67% versus 39% outside the therapeutic range. For amitriptyline, a significant curvilinear relationship between therapeutic response and total amitriptyline (amitriptyline+nortriptyline) concentration in plasma was observed between 93 and 140 ng/ml. The sensitivity and specificity for the total imipramine concentrations in plasma were 37 and 80%, respectively. The response rate within the therapeutic range was 50% versus 30% outside the therapeutic range.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7962678

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN: 0271-0749            Impact factor:   3.153


  18 in total

1.  Comparison of two approaches to amitriptyline dose individualisation.

Authors:  S M Janković; I Timotijević; G S Mihajlović; S Dukić-Dejanović
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1999 Apr-Jun       Impact factor: 2.441

Review 2.  Pharmacological treatment of depression in children and adolescents.

Authors:  R L Findling; M D Reed; J L Blumer
Journal:  Paediatr Drugs       Date:  1999 Jul-Sep       Impact factor: 3.022

3.  Comprehensive survey of the relationship between serum concentration and therapeutic effect of amitriptyline in depression.

Authors:  Sven Ulrich; Jürgen Läuter
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

4.  Amitriptyline does not block the action of ATP at human P2X4 receptor.

Authors:  J A Sim; R A North
Journal:  Br J Pharmacol       Date:  2010-03-19       Impact factor: 8.739

Review 5.  Therapeutic drug monitoring and pharmacogenetic tests as tools in pharmacovigilance.

Authors:  Eveline Jaquenoud Sirot; Jan Willem van der Velden; Katharina Rentsch; Chin B Eap; Pierre Baumann
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

6.  Imipramine dose in relation to therapeutic plasma level: are clinical trials using imipramine as a positive control flawed?

Authors:  Tom K Birkenhäger; Walter W van den Broek; Peter Moleman; Arnold G Vulto; Jan A Bruijn
Journal:  Psychopharmacology (Berl)       Date:  2005-10-12       Impact factor: 4.530

7.  Pharmacological Augmentation in Unipolar Depression: A Guide to the Guidelines.

Authors:  Rachael W Taylor; Lindsey Marwood; Emanuella Oprea; Valeria DeAngel; Sarah Mather; Beatrice Valentini; Roland Zahn; Allan H Young; Anthony J Cleare
Journal:  Int J Neuropsychopharmacol       Date:  2020-12-03       Impact factor: 5.176

8.  A drug repositioning approach identifies tricyclic antidepressants as inhibitors of small cell lung cancer and other neuroendocrine tumors.

Authors:  Nadine S Jahchan; Joel T Dudley; Pawel K Mazur; Natasha Flores; Dian Yang; Alec Palmerton; Anne-Flore Zmoos; Dedeepya Vaka; Kim Q T Tran; Margaret Zhou; Karolina Krasinska; Jonathan W Riess; Joel W Neal; Purvesh Khatri; Kwon S Park; Atul J Butte; Julien Sage
Journal:  Cancer Discov       Date:  2013-09-26       Impact factor: 39.397

Review 9.  Depression after lung transplantation: causes and treatment.

Authors:  P Fusar-Poli; M Lazzaretti; M Ceruti; R Hobson; K Petrouska; M Cortesi; E Pozzi; P Politi
Journal:  Lung       Date:  2007-03-28       Impact factor: 2.584

10.  Challenging the neuronal MIBG uptake by pharmacological intervention: effect of a single dose of oral amitriptyline on regional cardiac MIBG uptake.

Authors:  Montserrat Estorch; Ignasi Carrió; Esther Mena; Albert Flotats; Valle Camacho; Jordi Fuertes; Jaume Kulisewsky; Jagat Narula
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-06-19       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.